Drug Approval Considerations and Patent Linkage System in China

Yifan Mao, April Isaacson and Andrew Serafini are co-authors of "Drug Approval Considerations and Patent Linkage System in China," as featured in the American Bar Association's Third Edition of "Pre-ANDA Litigation: Strategies and Tactics for Developing a Drug Product and Patent Portfolio.

Regulatory Exclusivity Pre-ANDA Litigation: Strategies and Tactics for Developing a Drug Product and Patent Portfolio, Third Edition, July 1, 2022, written by Yifan Mao, April Isaacson and Andrew Serafini